REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
IFP Advisors, Inc 2,075$59,5520.00%
WOLVERINE TRADING, LLC 71,200$2,2160.00%
GROUP ONE TRADING, L.P. 27,793$895,2130.00%
AMALGAMATED BANK 11,412$3680.00%
Mirae Asset Global Investments Co., Ltd. 37,042$1,193,1230.00%
Walleye Capital LLC 5,500$177,1550.00%
AMERIPRISE FINANCIAL INC 280,982$9,050,4300.00%
Verition Fund Management LLC 7,373$237,4840.00%
BELLEVUE ASSET MANAGEMENT, LLC 93$2,9950.00%
Parallax Volatility Advisers, L.P. 24,747$797,1010.00%
Tower Research Capital LLC (TRC) 2,372$760.00%
Milestone Investment Advisors LLC 175$5,6370.00%
WASHINGTON TRUST Co 1,130$36,3970.00%
KEYBANK NATIONAL ASSOCIATION/OH 12,630$406,8130.00%
UBS Group AG 131,289$4,228,8190.00%
Russell Investments Group, Ltd. 28,404$914,8910.00%
MILLENNIUM MANAGEMENT LLC 112,567$3,6260.00%
NEW YORK STATE COMMON RETIREMENT FUND 42,490$1,3690.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 23,381$753,1020.00%
Janney Montgomery Scott LLC 18,560$5980.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.